<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>113</volume><submitter>Hou X</submitter><funding>Guangxi Natural Science Foundation</funding><funding>Guilin Science and Technology Bureau</funding><funding>China Postdoctoral Science Foundation</funding><funding>Guangxi Science and Technology Department</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global health emergency. T-cell receptors (TCRs) are crucial mediators of antiviral adaptive immunity. This study sought to comprehensively characterize the TCR repertoire changes in patients with COVID-19.&lt;h4>Methods&lt;/h4>A large sample size multi-center randomized controlled trial was implemented to study the features of the TCR repertoire and identify COVID-19 disease-related TCR sequences.&lt;h4>Results&lt;/h4>It was found that some T-cell receptor beta chain (TCRβ) features differed markedly between COVID-19 patients and healthy controls, including decreased repertoire diversity, longer complementarity-determining region 3 (CDR3) length, skewed utilizat</pubmed_abstract><journal>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</journal><pagination>308-317</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8530772</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19.</pubmed_title><pmcid>PMC8530772</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Mo C</pubmed_authors><pubmed_authors>Wen X</pubmed_authors><pubmed_authors>Fan W</pubmed_authors><pubmed_authors>He D</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Mo L</pubmed_authors><pubmed_authors>Jiang S</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Hou X</pubmed_authors><pubmed_authors>Gong W</pubmed_authors><pubmed_authors>Ou M</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19.</name><description>&lt;h4>Objective&lt;/h4>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing global health emergency. T-cell receptors (TCRs) are crucial mediators of antiviral adaptive immunity. This study sought to comprehensively characterize the TCR repertoire changes in patients with COVID-19.&lt;h4>Methods&lt;/h4>A large sample size multi-center randomized controlled trial was implemented to study the features of the TCR repertoire and identify COVID-19 disease-related TCR sequences.&lt;h4>Results&lt;/h4>It was found that some T-cell receptor beta chain (TCRβ) features differed markedly between COVID-19 patients and healthy controls, including decreased repertoire diversity, longer complementarity-determining region 3 (CDR3) length, skewed utilizat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-22T20:49:02.077Z</modification><creation>2025-04-06T03:15:36.338Z</creation></dates><accession>S-EPMC8530772</accession><cross_references><pubmed>34688948</pubmed><doi>10.1016/j.ijid.2021.10.033</doi></cross_references></HashMap>